Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Employment test 11 - 50 employees
Company dna cabinet ores
operating since 1972
925.19
Headquarter in Paris
active in Legal Services, IP Consulting, and Matchmaking and Trading

We have observed 21 EP applications Claire Jacqueline Bernstein has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 17, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11715751

BACILLUS PUMILUS BILIRUBIN OXIDASE AND APPLICATIONS THEREOF

IPC classification:
C07K 14/32, C12N 9/04
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Agent:
Claire Jacqueline Bernstein, Gevers & Orès
Status:
PATENT GRANTED
EP11794236

USE OF QUINOLINONE DERIVATIVES AS A RESEARCH TOOL

IPC classification:
G01N 33/566
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Agent:
Claire Jacqueline Bernstein, Gevers & Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11794858

QUINOLINONE DERIVATIVES

IPC classification:
A61K 31/4704, A61P 19/00
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Agent:
Claire Jacqueline Bernstein, Gevers & Orès
Status:
The patent has been granted
EP12195560

Pharmaceutical composition containing an N-phenylpyrazole derivative, use for the preparation of a topical veterinary drug for flea control

IPC classification:
A01N 25/02, A01N 47/02, A01P 7/04, A61K 9/00, A61K 31/415, A61K 47/34, A61P 33/14
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Agent:
Claire Jacqueline Bernstein, Gevers & Orès
Status:
PATENT GRANTED
EP12725522

BILIRUBIN OXIDASE FROM MAGNAPORTHE ORYZAE AND APPLICATIONS THEREOF

IPC classification:
C12N 9/00, C12N 15/53, C12N 15/81, C12Q 1/00, C12Q 1/26, G01N 21/78, G01N 27/327, G01N 33/72, H01M 4/86, H01M 4/90, H01M 8/16
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Agent:
Claire Jacqueline Bernstein, Gevers & Orès
Status:
GRANT OF PATENT INTENDED
EP12306297

Novel compounds with protective activity against toxins with intracellular action mode

IPC classification:
A61K 31/381, A61K 31/427, A61K 31/4439, A61K 31/506, A61K 31/517, A61P 39/02, C07D 239/91, C07D 409/04, C07D 409/14, C07D 417/14
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Applicant:
Institut Curie
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12306299

2,3-dihydroquinazolin-4(1H)-one derivatives for use in the treatment of viral infections

IPC classification:
A61K 31/517, A61P 31/12, C07D 239/00
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Applicant:
The University of Texas Medical Branch
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12724730

COMPOSTER TO BE VERTICALLY ATTACHED

IPC classification:
C05F 17/00, C05F 17/02
Agent:
Multiple attorneys, Cabinet Orès
Agent:
Claire Jacqueline Bernstein, Gevers & Orès
Status:
GRANT OF PATENT INTENDED
EP12798863

COMBINATION OF A NANOPARTICLE COMPRISING A CHARGED CORE MADE OF PHOSPHOLIPID WITH A PROTEIN - USE FOR THE IN VITRO DELIVERY OF SAID PROTEIN

IPC classification:
A61K 9/127, A61K 9/51, A61K 49/18
Applicant:
Université de Droit et de la Santé de Lille 2
Applicant:
Centre Hospitalier Régional et Universitaire de Lille
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Agent:
Claire Jacqueline Bernstein, Gevers & Orès
Agent:
IP Trust SAS
Status:
EXAMINATION IN PROGRESS
EP12773126

PENICILLIUM AMAGASAKIENSE GLUCOSE OXIDASE MUTANTS

IPC classification:
C12N 9/00, C12N 9/02, C12N 9/04, C12N 15/52
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Agent:
Claire Jacqueline Bernstein, Gevers & Orès
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13736198

FIXED DOSE COMBINATION THERAPY OF PARKINSON'S DISEASE

IPC classification:
A61K 9/22, A61K 9/48, A61K 31/137, A61K 31/4045, A61K 45/06, A61P 25/16
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Agent:
Claire Jacqueline Bernstein, Gevers & Orès
Status:
EXAMINATION IN PROGRESS
EP13305815

Alkoxyamines for the treatment of cancers

IPC classification:
A61P 35/00, C07C 239/20, C07F 9/40
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université de Bordeaux
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13174079

Composition for the treatment of progressive renal diseases

IPC classification:
A61K 31/122, A61K 31/202, A61K 31/352, A61K 31/375, A61K 31/59, A61K 31/715, A61K 31/722, A61K 33/06, A61K 38/08, A61K 45/06, A61K 47/36, A61P 13/12
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Agent:
Claire Jacqueline Bernstein, Gevers & Orès
Status:
GRANT OF PATENT INTENDED
EP13306099

Method of crystallization of membrane proteins and to compositions, devices and kits to conduct such method

IPC classification:
C07K 1/30
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Agent:
Claire Jacqueline Bernstein, Gevers & Orès
Status:
GRANT OF PATENT INTENDED
EP13735432

LACCASE FROM PODOSPORA ANSERINA AND ITS USES

IPC classification:
A23L 1/22, A23L 3/3571, A61K 8/66, A61K 38/44, C11D 3/386, C12N 9/00, C12N 9/02, C12P 7/06, H01M 4/00
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Agent:
Claire Jacqueline Bernstein, Gevers & Orès
Status:
GRANT OF PATENT INTENDED
EP13306606

Sweet food product made of dried fruit

IPC classification:
A23G 3/34, A23G 3/48
Applicant:
Sanofi
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Agent:
Claire Jacqueline Bernstein, Gevers & Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14198365

Dry cheese or dairy snack food product and method for manufacturing same

IPC classification:
A23C 19/00, A23C 19/09
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Agent:
Claire Jacqueline Bernstein, Gevers & Orès
Status:
PATENT GRANTED
EP13826884

PHARMACEUTICAL COMPOSITION CONTAINING A DERIVATIVE OF N-PHENYLPYRAZOLE AND PERMETHRIN, AND USE FOR THE PRODUCTION OF A TOPICAL VETERINARY MEDICAMENT

IPC classification:
A61K 9/00, A61K 31/222, A61K 31/415, A61K 31/4402, A61K 45/06
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Agent:
Claire Jacqueline Bernstein, Gevers & Orès
Status:
GRANT OF PATENT INTENDED
EP13828846

NOVEL VETERINARY PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF

IPC classification:
A61K 9/10, A61K 31/192, A61K 47/14
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Agent:
Claire Jacqueline Bernstein, Gevers & Orès
Status:
GRANT OF PATENT INTENDED
EP11727550

FUNCTIONALIZED MEMBRANE FOR A CHAMBER FOR ENCAPSULATING CELLS PRODUCING AT LEAST ONE SUBSTANCE OF THERAPEUTIC INTEREST AND BIOARTIFICIAL ORGAN COMPRISING SUCH A MEMBRANE

IPC classification:
A61F 2/02, A61L 27/54, B01D 67/00
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11764867

NOVEL GENE VACCINATION LIPOSOMES

IPC classification:
A61K 9/00, A61K 9/127, A61K 47/48, A61K 48/00
Applicant:
Cirad (Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement)
Agent:
Claire Jacqueline Bernstein, Cabinet Orès
Agent:
Claire Jacqueline Bernstein, Gevers & Orès
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature